Evaluation of complement proteins as screening markers for colorectal cancer.

Cancer immunology, immunotherapy : CII (2015 Jan)
Issue 1 p. 41-50 issn:1432-0851)

Colorectal cancer (CRC) is a leading cause of cancer death worldwide. Lack of symptoms results in late detection and increased mortality. Inflammation, including complement activation, plays an important role in tumorigenesis.

Forfattere: Storm L, Christensen IJ, Jensenius JC, Nielsen HJ, Thiel S,

Se på Pub MED

Print Friendly, PDF & Email

Donation / Partnerskab

Er du interesseret i at donere til vores forskning som privatperson, virksomhed eller forening?

Dit navn *

Din e-mail *

Dit tlf. nummer

Din besked *

  Emne

Kontaktoplysninger

ColoRectal Cancer Research

Gastroenheden, Hvidovre Hospital

Kettegård Allé 30

2650 Hvidovre

Email: info@colorectalcancer.dk